Hutch News

Stories tagged 'Vaccine and Infectious Disease Division (VIDD)'

A big-picture look at the world’s worst Ebola epidemic

International team of scientists show how real-time sequencing and data-sharing can help stop the next outbreak

April 12, 2017 | By Mary Engel / Fred Hutch News Service

An international team of scientists analyzed 1,610 Ebola virus genomes for the most comprehensive look to date at the how the 2013-2016 epidemic spread, proliferated and declined across the three West African countries most affected.

View story >


Common cold can be surprisingly dangerous for transplant patients

Study shows typically ‘mild’ respiratory virus can turn into deadly pneumonia in this vulnerable population, points to need for effective meds, better prevention

March 7, 2017 | By Rachel Tompa / Fred Hutch News Service

The common cold is a major source of annoyance for most of us, but new research has found that for bone marrow transplant patients, this most common respiratory infection can be far worse than just a stuffy nose.

View story >


Open Science Prize goes to software tool for tracking viral outbreaks

Nextstrain wins international competition by making it easier to share, analyze genetic-sequencing data of spreading viruses

Feb. 28, 2017 | By Mary Engel / Fred Hutch News Service

After three rounds of competition — one of which involved a public vote — a software tool developed by researchers at Fred Hutchinson Cancer Research Center and the University of Basel to track Zika, Ebola and other viral disease outbreaks in real time has won the first-ever international Open Science Prize.

View story >


'We've become full partners'

An HIV laboratory in South Africa advances scientific understanding, and more

Jan. 6, 2017 | By Mary Engel / Fred Hutch News Service

Fred Hutch immunologist Dr. Erica Andersen-Nissen moved to Cape Town, South Africa, in 2013 to set up a state-of-the-art HIV laboratory to anchor two groundbreaking vaccine clinical trials. This is the story of building that lab, from the people up.

View story >


On the path to a new-generation malaria vaccine

New approach using genetically modified parasite ‘primes the immune system’ in first human trial

Jan. 4, 2017 | By Mary Engel / Fred Hutch News Service

Volunteers in a clinical trial led by Fred Hutch's Dr. Jim Kublin endured 150 to 200 mosquito bites in one 10-minute session to test a new approach to a malaria vaccine that uses genetically attenuated, or weakened, parasites to stimulate an immune response to malaria without causing disease.

View story >


Looking back at the future

A roundup of some of our favorite 2016 stories on research at Fred Hutch

Dec. 30, 2016 | By Fred Hutch News Service staff

At Fred Hutch News Service, our writers witness daily the excitement of covering new developments in the science of cancer and the human immune system. As 2016 draws to a close, we asked them to sort through the stories about Fred Hutch research they had written this year, and offer our readers a selection of those they felt were most meaningful and important.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.